ALT5 Sigma
Blockchain payments and trading infrastructure for enterprise digital asset activity.
Something off on this page? Send us feedback.
Profile
ALT5 Sigma provides digital asset payment, trading and settlement infrastructure through ALT5 Pay, ALT5 Prime and StrataCarte. Its business serves institutions and merchants, while a WLFI token treasury and legacy biotech assets add separate structural exposures.
ALT5 Sigma is a fintech company built around digital asset infrastructure rather than consumer crypto apps. Its Fintech & Payments operations center on ALT5 Pay for merchant and platform payment acceptance, ALT5 Prime for over-the-counter digital asset trading, and StrataCarte for multi-currency card programs tied to Visa and Mastercard networks.
The company markets these tools to banks, broker-dealers, funds, family offices, trading firms, payment service providers and merchants, earning through setup, maintenance, spread and transaction fees. It also maintains a WLFI token treasury and retains Alyea Therapeutics, a legacy clinical-stage biotech business that the company has discussed separating. The operating model depends on regulated access to digital assets, reliable banking and custody partners, and controls for KYC, transaction monitoring and anti-money laundering compliance.
Company facts
Key statistics
Year to date −29.3% · Average volume (30d) 886.6K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| May 20, 2026Q1 FY26 | −$0.14 | −$2.14 | −1,428.6% | $15.3M | $4.7M | −69.2% | +4.08% |
| Apr 13, 2026Q1 FY26 | −$0.18 | −$6.54 | −3,533.3% | $15.6M | $5.4M | −65.6% | −2.92% |
| Jan 12, 2026Q4 FY25 | −$0.36 | $0.67 | +286.1% | $10.0M | $7.6M | −24.1% | +12.42% |
| Aug 12, 2025Q2 FY25 | −$0.13 | −$0.49 | −278.0% | $5.9M | $6.4M | +8.1% | +16.78% |
Financial highlights
| 12 quarters | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $5.4M | $5.5M | $6.4M | $7.6M | $5.4M | $4.7M | |
| Gross profit | $2.8M | $2.6M | $2.8M | $1.7M | $2.2M | $3.6M | |
| Operating income | −$1.6M | −$2.2M | −$2.1M | −$16.5M | −$2.6M | −$2.7M | |
| Net income | −$3.9M | −$2.9M | −$9.1M | $49.0M | −$381.5M | −$271.5M | |
| Diluted EPS | −$0.25 | −$0.18 | −$0.49 | $1.27 | −$6.54 | −$2.14 | |
| Gross margin | 52.3% | 47.0% | 43.5% | 22.7% | 40.9% | 75.8% | |
| Operating margin | -29.9% | -39.4% | -32.8% | -218.3% | -48.1% | -58.2% |
Fiscal years (4-quarter sums)FY24 $12.5M · FY25 $24.8M
Balance sheet, Mar 31, 2026Cash & short-term investments $15.5M · Total debt $28.5M · Total assets $959.7M · Shareholders' equity $889.7M
Dividends
Last cut to $0.064 from $0.461 in Apr 2022.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Apr 1, 2022 | Apr 4 | Apr 8 | $0.064 | cut from $0.461 |
| Dec 30, 2021 | Dec 31 | Jan 6 | $0.461 | raised from $0.35 |
| Oct 1, 2021 | Oct 4 | Oct 8 | $0.35 |
Ownership
Shares outstanding 139.84M · Float 136.66M
This issuer lists more than one class and the share count spans them all, so a stake here reads as a share of the whole company, not of this class.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % of company | Form | Filed |
|---|---|---|---|---|
| CRCM LP | 12.61M | 9.02% | 13F | May 13, 2026 |
| Diametric Capital, LP | 6.20M | 4.43% | 13F | May 15, 2026 |
| Vanguard Capital Management LLC | 5.48M | 3.92% | 13F | May 15, 2026 |
| Prelude Capital Management, LLC | 2.95M | 2.11% | 13F | May 15, 2026 |
| BlackRock, Inc. | 2.79M | 2.00% | 13F | May 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 14, 2025 | David C. Danziger | director | +10,000 | $7.30 |
Peers
Not reported.